par Douchamps, J;Derenne, F;Stockis, A;Gangji, D;Juvent, Michèle;Herchuelz, André
Référence European Journal of Clinical Pharmacology, 35, 5, page (515-520)
Publication Publié, 1988
Référence European Journal of Clinical Pharmacology, 35, 5, page (515-520)
Publication Publié, 1988
Article révisé par les pairs
Titre: |
|
Auteur: | Douchamps, J; Derenne, F; Stockis, A; Gangji, D; Juvent, Michèle; Herchuelz, André |
Informations sur la publication: | European Journal of Clinical Pharmacology, 35, 5, page (515-520) |
Statut de publication: | Publié, 1988 |
Sujet CREF: | Sciences bio-médicales et agricoles |
Mots-clés: | debrisoquine |
genetic polymorphism | |
health volunteers | |
oxybutynin | |
pharmacokinetics | |
MeSH keywords: | Administration, Oral |
Adult | |
Biological Availability | |
Debrisoquin -- metabolism | |
Drug Tolerance | |
Female | |
Half-Life | |
Humans | |
Hydroxylation | |
Injections, Intravenous | |
Intestinal Absorption | |
Male | |
Mandelic Acids -- administration & dosage | |
Mandelic Acids -- blood | |
Mandelic Acids -- pharmacokinetics | |
Parasympatholytics -- administration & dosage | |
Parasympatholytics -- blood | |
Parasympatholytics -- pharmacokinetics | |
Solutions | |
Tablets | |
Note générale: | Comparative Study |
Journal Article | |
Research Support, Non-U.S. Gov't | |
SCOPUS: ar.j | |
Langue: | Anglais |
Identificateurs: | urn:issn:0031-6970 |
info:doi/10.1007/BF00558247 | |
info:scp/0023732376 | |
info:pmid/3234461 |